Patrizia Casalini Selected Research

Adenocarcinoma

1/2018

Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrizia Casalini Research Topics

Disease

27	Neoplasms (Cancer) 01/2019 - 01/2002
20	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2002
4	Carcinoma (Carcinomatosis) 06/2014 - 07/2004
3	Triple Negative Breast Neoplasms 01/2016 - 08/2012
3	Carcinogenesis 03/2009 - 09/2004
2	Inflammation (Inflammations) 04/2018 - 12/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019
1	Hypoxia (Hypoxemia) 04/2018
1	Starvation 04/2018
1	Iron Deficiencies 04/2018
1	Adenocarcinoma 01/2018
1	Disease Progression 06/2014
1	Neoplastic Processes 05/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014
1	Vasculitis (Vasculitides) 10/2012
1	Fibrosis (Cirrhosis) 12/2011
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2011
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 10/2011
1	medullary Thyroid cancer 10/2011
1	Angiosarcoma of the breast 11/2010
1	Myxoid Liposarcoma 07/2010
1	Neoplasm Metastasis (Metastasis) 01/2008
1	Ovarian Neoplasms (Ovarian Cancer) 09/2007
1	Ovarian Epithelial Carcinoma 09/2007

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 06/2018 - 09/2007
7	Proteins (Proteins, Gene)FDA Link 05/2018 - 03/2004
4	Phosphotransferases (Kinase)IBA 10/2011 - 09/2004
3	Messenger RNA (mRNA)IBA 01/2019 - 12/2008
3	Pharmaceutical PreparationsIBA 06/2018 - 01/2008
3	Monoclonal AntibodiesIBA 06/2014 - 01/2002
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 06/2018
2	human ERBB2 proteinIBA 01/2019 - 02/2003
2	Biomarkers (Surrogate Marker)IBA 06/2018 - 10/2011
2	LipidsIBA 04/2018 - 10/2011
2	Epidermal Growth Factor (EGF)IBA 11/2015 - 05/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2014 - 02/2003
2	CollagenIBA 06/2014 - 12/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2011 - 05/2006
2	Oncogene Proteins (Oncogene Protein)IBA 10/2011 - 05/2006
2	3' Untranslated Regions (3' UTR)IBA 10/2011 - 12/2008
2	tyrosine receptor (receptor, tyrosine)IBA 07/2010 - 09/2004
2	Complementary DNA (cDNA)IBA 03/2004 - 01/2002
2	Hormones (Hormone)IBA 06/2003 - 02/2002
1	Toll-Like Receptor 3IBA 10/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Chelating AgentsIBA 04/2018
1	IronIBA 04/2018
1	Deferoxamine (Desferal)FDA LinkGeneric 04/2018
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2018
1	CD40 Ligand (CD40L)IBA 01/2018
1	cadherin 5IBA 01/2017
1	fragile histidine triad proteinIBA 11/2015
1	Proteasome InhibitorsIBA 11/2015
1	matrigelIBA 06/2014
1	Liposomes (Liposome)IBA 06/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2014
1	SerpinsIBA 06/2014
1	SERPIN-B5 (maspin)IBA 06/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2013
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2012
1	indium-bleomycinIBA 12/2011
1	Cysteine (L-Cysteine)FDA Link 12/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011
1	Biological ProductsIBA 10/2011
1	Tyrosine (L-Tyrosine)FDA Link 10/2011
1	Caspase 8 (Caspase-8)IBA 10/2011
1	Death Domain ReceptorsIBA 10/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2010
1	TrabectedinIBA 07/2010
1	LigandsIBA 07/2010
1	RetinoidsIBA 12/2009
1	Estrogens (Estrogen)FDA Link 12/2009
1	Estrogen ReceptorsIBA 12/2009
1	FenretinideIBA 12/2009
1	4-oxofenretinideIBA 12/2009
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 04/2009
1	4- (5,6- dichloro- 1H- indol- 2- yl)- 3- ethoxy- N- (2,2,6,6- tetramethylpiperidin- 4- yl)benzamideIBA 01/2008
1	indoleIBA 01/2008
1	EnzymesIBA 01/2008
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 01/2008
1	benzamideIBA 01/2008
1	Hyaluronic Acid (Hyaluronan)IBA 01/2008
1	AntigensIBA 10/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2007
1	Decitabine FDA Link 09/2007
1	DNA (Deoxyribonucleic Acid)IBA 09/2007
1	ErbB Receptors (EGF Receptor)IBA 09/2004
1	RNA (Ribonucleic Acid)IBA 03/2004
1	Glycoproteins (Glycoprotein)IBA 03/2004
1	Tamoxifen FDA LinkGeneric 06/2003
1	Therapeutic UsesIBA 02/2003

Therapy/Procedure

9	Therapeutics 01/2016 - 02/2003
2	Drug Therapy (Chemotherapy) 06/2014 - 07/2010
2	Radiotherapy 01/2013 - 07/2010
1	Molecular Targeted Therapy 05/2018
1	Immunotherapy 01/2018
1	Oral Administration 01/2008
1	Hysterectomy 06/2003
1	Adjuvant Chemotherapy 02/2003